Plain-English translation of NCT07105111 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Read our Schizophrenia research guide โPhase 4 โ The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial is testing a medication called to see if it can help reduce involuntary movements (like twitching or jerking) that sometimes develop as a side effect of psychiatric medications. The study will look at how well the medication works based on both what doctors observe and how patients themselves feel over 24 weeks.
Some people taking medications for conditions like schizophrenia, bipolar disorder, or depression develop involuntary movements as a side effect. This medication is already approved for this condition, but researchers want to understand how well it works in people who are still having symptoms despite other treatments they may have tried.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
You would take the medication once by mouth every day for 24 weeks (about 6 months). During this time, you would have clinic visits where doctors and nurses will watch for changes in your involuntary movements and ask you how you're feeling. The study team will also check your heart health and overall well-being throughout the trial.
AI-generated summary from trial data ยท Jun 2, 2026 ยท Not medical advice
United States